Bristol-Myers Squibb Company (BMY)

Marco Green
September 18, 2017

Montag & Caldwell Llc sold 1.39 million shares as Bristol (BMY)'s stock declined 1.04%. Alpha Windward Limited Liability Company owns 5,376 shares. Colony Gru Ltd Company invested in 10,308 shares.

September 15 investment analysts at Jefferies left the stock rating at "Buy" and moved up the price target from $65.00 to $72.00. About shares traded. Becton Dickinson and Co (NYSE:BDX) has risen 12.32% since September 18, 2016 and is uptrending. It has underperformed by 31.85% the S&P500. Management Of Virginia Limited Liability Corp invested 0.4% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). American National Bank now owns 1,919 shares of the biopharmaceutical company's stock valued at $104,000 after acquiring an additional 508 shares during the period. The Wilbanks Smith & Thomas Asset Management Llc holds 73,046 shares with $4.27M value, up from 34,789 last quarter. The company has market cap of $2.59 billion. The stock decreased 0.17% or $0.15 on September 15, reaching $89.56. It has underperformed by 39.89% the S&P500.

Investors sentiment increased to 1.17 in 2016 Q4. Its up 0.31, from 0.87 in 2016Q3. It dived, as 86 investors sold BMY shares while 529 reduced holdings. Ls Ltd accumulated 23,726 shares. Piper Jaffray upgraded the shares of BMY in report on Monday, August 24 to "Underweight" rating.

The company reported its EPS on 6/29/2017. Principal Financial Grp Incorporated holds 0.04% or 1.01 million shares. Investors of record on Friday, October 6th will be paid a $0.39 dividend. Addison Cap invested in 18,199 shares. Salzhauer Michael holds 0.08% or 2,786 shares. The Florida-based Raymond James Svcs has invested 0% in Antero Resources Corp (NYSE:AR). Fruth Invest Mngmt holds 0.09% or 1,240 shares. The stock grabbed 107 new institutional investments totaling 4,488,236 shares while 84 institutional investors sold out their entire positions totaling 11,367,615 shares. (NYSE:OKE) has "Overweight" rating given on Monday, May 9 by Barclays Capital. Tealwood Asset stated it has 0.66% in Becton Dickinson and Co (NYSE:BDX).

Analysts await SCANA Corporation (NYSE:SCG) to report earnings on October, 26. They expect $-0.03 earnings per share, down 125.00% or $0.15 from last year's $0.12 per share. SCG's profit will be $161.46M for 13.24 P/E if the $1.13 EPS becomes a reality. The biopharmaceutical company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.01. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.76%. Parametric Port Lc, a Washington-based fund reported 368,994 shares. Goldman Sachs Group, Inc. The rating was maintained by Leerink Swann on Thursday, July 27 with "Buy". On Monday, April 3 the stock rating was upgraded by Susquehanna to "Positive". Morgan Stanley downgraded the shares of SCG in report on Wednesday, June 15 to "Underweight" rating. The rating was maintained by Stifel Nicolaus on Thursday, August 3 with "Buy". Jefferies maintained Becton Dickinson and Co (NYSE:BDX) on Friday, June 9 with "Buy" rating.

More notable recent SCANA Corporation (NYSE:SCG) news were published by: which released: "Scana Corporation (SCG) Ex-Dividend Date Scheduled for September 08, 2017" on September 07, 2017, also with their article: "SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of SCANA Corporation" published on September 08, 2017, published: "Bragar Eagel & Squire, PC is Investigating SCANA Corporation (SCG) on Behalf ..." on September 11, 2017. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & global copyright and trademark laws. First New York Securities LLC NY acquired a new position in Bristol-Myers Squibb Company during the third quarter worth approximately $108,000. Osborne Prns Capital Ltd Company has 1% invested in Bristol-Myers Squibb Co (NYSE:BMY). Bristol-Myers Squibb's payout ratio is presently 56.73%.

Why Bristol-Myers Squibb Company (BMY) stock is considered to be Overbought? The Veritable Lp holds 258,164 shares with $15.09M value, up from 10,000 last quarter.

Since May 12, 2017, it had 0 buys, and 5 insider sales for $3.50 million activity. $1.81 million worth of Bristol-Myers Squibb Co (NYSE:BMY) was sold by ANDREOTTI LAMBERTO.

Investors sentiment decreased to 0.95 in Q4 2016. Its down 0.03, from 0.98 in 2016Q3.

Other large investors have also recently added to or reduced their stakes in the company. 126 funds opened positions while 468 raised stakes.

Bristol-Myers Squibb (NYSE BMY) traded down 0.33% during mid-day trading on Friday, reaching $62.48. Moreover, Northwestern Mutual Wealth Management has 0.06% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 92,031 shares.

Among 16 analysts covering Becton Dickinson (NYSE:BDX), 8 have Buy rating, 1 Sell and 7 Hold. 48,950 are owned by Raab Moskowitz Asset Mngmt Limited Liability Co. Davidson Inv has 1,850 shares. Dekabank Deutsche Girozentrale reported 254,806 shares. Bingham Osborn Scarborough Limited Liability Corp reported 0.05% stake. Grantham Mayo Van Otterloo & Limited Liability accumulated 0.68% or 764,568 shares. Wellington Gp Limited Liability Partnership owns 10.21M shares or 0.06% of their USA portfolio. Hm Payson, a Maine-based fund reported 92,029 shares. Parametric Portfolio Associates Ltd Com holds 313,328 shares. Concert Wealth Mngmt reported 36,893 shares. Penserra Capital Management LLC increased its position in Bristol-Myers Squibb Company by 95.3% in the third quarter. Therefore 61% are positive. Bristol-Myers Squibb Company had 53 analyst reports since July 28, 2015 according to SRatingsIntel. (NYSE:WWW). Deutsche Bancorp Ag reported 117,067 shares. The firm has "Buy" rating by Jefferies given on Monday, December 19. The firm has "Equal-Weight" rating by Barclays Capital given on Friday, September 9. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned "Hold" rating by Hilliard Lyons on Tuesday, September 12. Finally, Vetr raised Bristol-Myers Squibb from a "buy" rating to a "strong-buy" rating and set a $64.08 target price on the stock in a report on Thursday, August 17th. As per Monday, February 8, the company rating was downgraded by Evercore.

Other reports by Click Lancashire

Discuss This Article